Home
BioXcel Therapeutics

BioXcel Therapeutics Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domainbioxceltherapeutics.com

Year Founded2017

Employees51 - 200

Annual Revenue$15M - $25M

BioXcel Therapeutics

BioXcel Therapeutics (including company regionals)

bioxceltherapeutics.com

See more website traffic and engagement information

BioXcel Therapeutics Revenue up to August 2026 is 15M - 25M

revenue generated by BioXcel Therapeutics top domains

BioXcel Therapeutics top domains revenue over 3 years

Revenue for BioXcel Therapeutics top domains

bioxceltherapeutics.com15M - 25M

See more with Sales Intelligence

Total visits to BioXcel Therapeutics's top domains

Understand BioXcel Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bioxceltherapeutics.com6.2K

See more with Sales Intelligence

Avg. visit duration in BioXcel Therapeutics's top domains

Analyze BioXcel Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bioxceltherapeutics.com00:00:12

See more with Sales Intelligence

Avg. pageviews on BioXcel Therapeutics's top domains

See how BioXcel Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bioxceltherapeutics.com1.50

See more with Sales Intelligence

BioXcel Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

exelixis.comCompany NameExelixisEmployees1001 - 5000HQUnited States, California, AlamedaAnnual revenue> $1BTotal visits22.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by BioXcel Therapeutics

These are the website technologies, by industry, used by BioXcel Therapeutics top domains

Payment & Currencies (8)

Cart Functionality

Widget (5)

Twemoji

Content Management System (4)

WordPress

eCommerce (3)

WooCommerce

More Technologies

9

See all

News & Signals from BioXcel Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioXcel Therapeutics Inc. declared bankruptcy on Aug 28th '26.New Haven biotech BioXcel files for bankruptcy, agrees to potential $145M sale.

NewsBioXcel Therapeutics Inc. sold assets to Teva Pharmaceutical Industries Ltd. in the amount of $125M on Aug 28th '26.Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced it has made a bid to acquire an innovative neuroscience product from BioXcel Therapeutics, Inc. through a court-supervised sale process.

NewsBioXcel Therapeutics Inc. declared bankruptcy under Chapter 11 on Aug 28th '26.BioXcel Therapeutics (NASDAQ: BTAI) stock collapsed approximately 75% in post - market trading on August 28, 2026, after the biopharmaceutical company filed for Chapter 11 bankruptcy protection in the United States.